Thomas Daniel

Directeur/Membre du Conseil chez GOSSAMER BIO, INC. Fortune : 8 800 $ au 31/05/2026

Profil

Thomas O.
Daniel is currently Chairman-Overseers Board at The Scripps Research Institute; Chairman at Locanabio, Inc. since 2017; Chairman at Life Science Cares San Diego LLC; Chairman at Gate Therapeutics; Chairman at Trotana, Inc.; Director at FerruMax Pharmaceuticals, Inc.; Director at Lupus Research Alliance, Inc.; Independent Director at Gossamer Bio, Inc. since 2018; Director at Aspen Neuroscience, Inc. since 2020; Director at Mozart Therapeutics, Inc. since 2020; and Trustee at The Reed Institute since 2017.
Former roles include Chairman-Research Division at Celgene Corp.
in 2016; Independent Director at Zafgen, Inc. from 2016 to 2020; Director at Abide Therapeutics, Inc.; Director at PharmAkea, Inc.; Chief Scientific Officer & Director at Ambrx, Inc.; Director at Alliance for Lupus Research; Director at Pharmaceutical Research & Manufacturers of America; Director at Epizyme, Inc. from 2012 to 2014; Director at Epizyme, Inc.; Director at ImmusanT, Inc. from 2017 to 2019; Independent Director at Juno Therapeutics, Inc. from 2015 to 2018; Executive Director at Catalyst Advisors LP; Independent Director at Magenta Therapeutics, Inc.; Independent Director at Vir Biotechnology, Inc.; Director at Vanderbilt Vascular Biology Center; Director at Sana Biotechnology, Inc.; Independent Director at Larimar Therapeutics, Inc. from 2020 to 2022; Director at Vividion Therapeutics, Inc.; Vice President-Research at Amgen, Inc. from 2002 to 2003; Senior Vice President-Discovery Research at Immunex Corp.
from 2000 to 2002; Venture Partner at ARCH Venture Partners LLC from 2016 to 2021; and Professor at Vanderbilt University.
Education includes an undergraduate degree from Southern Methodist University in 1974; a doctorate from The University of Texas at Austin in 1978; and a doctorate from The University of Texas Southwestern Medical Center in 1978.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
GOSSAMER BIO, INC. 0,01 %	04/06/2026	38 095 ( 0,01 % )	8 800 $	31/05/2026

Postes actifs de Thomas Daniel

Sociétés	Poste	Début
GOSSAMER BIO, INC.	Directeur/Membre du Conseil	01/01/2018
Lupus Research Alliance, Inc.	Directeur/Membre du Conseil	-
Aspen Neuroscience, Inc.	Directeur/Membre du Conseil	01/02/2020
Mozart Therapeutics, Inc.	Directeur/Membre du Conseil	01/06/2020
Trotana, Inc.	Président	-
The Reed Institute	Directeur/Membre du Conseil	01/03/2017
Locanabio, Inc.	Président	-
The Scripps Research Institute	Corporate Officer/Principal	-
FerruMax Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Thomas Daniel

Sociétés	Poste	Fin
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░ ░░░	░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░